STRAND MEDICAL GROUP
1B THE CAUSEWAY, GORING-BY-SEA, WORTHING
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 14 | 23 | 60.9% | |
| HF 4 | 2011 | 15 | 24 | 62.5% | |
| HF 4 | 2012 | 12 | 19 | 63.2% | |
| HF 4 | 2013 | 17 | 24 | 70.8% | |
| HF004 | 2014 | 8 | 11 | 72.7% | |
| HF004 | 2015 | 7 | 9 | 77.8% | |
| HF004 | 2016 | 30 | 34 | 88.2% | |
| HF004 | 2017 | 32 | 36 | 88.9% | |
| HF004 | 2018 | 44 | 50 | 88.0% | |
| HF004 | 2019 | 51 | 56 | 91.1% | |
| HF004 | 2020 | 45 | 52 | 86.5% | |
| HF006 | 2021 | 57 | 73 | 78.1% | |
| HF006 | 2022 | 73 | 75 | 97.3% | |
| HF006 | 2023 | 78 | 83 | 94.0% |
